| Counseling & Disability Services | |
|
1635 S Ridgewood Ave Ste 225 South Daytona FL 32119-8478 | |
| (386) 788-5021 | |
| (386) 788-5021 |
| Full Name | Counseling & Disability Services |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 1635 S Ridgewood Ave Ste 225, South Daytona, Florida |
| Authorized Official Name and Position | Phyllis Ann Lavigna (OWNER/MANAGER) |
| Authorized Official Contact | 3867885021 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Counseling & Disability Services 1635 S Ridgewood Ave Ste 225 South Daytona FL 32119-8478 Ph: (386) 788-5021 | Counseling & Disability Services 1635 S Ridgewood Ave Ste 225 South Daytona FL 32119-8478 Ph: (386) 788-5021 |
| NPI Number | 1518205152 |
|---|---|
| Provider Enumeration Date | 01/16/2013 |
| Last Update Date | 03/14/2024 |
| Certification Date | 03/14/2024 |
| Medicare PECOS PAC ID | 2769618040 |
|---|---|
| Medicare Enrollment ID | O20131114000988 |
News Archive
Of the more than 38,000 Americans diagnosed with renal cell carcinoma each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib - a standard frontline treatment for RCC.
VACUSIP is a portable benchtop vacuum aspiration system from INTEGRA that you can place wherever you need it. Besides increased mobility, the battery version of the VACUSIP allows you to keep the workspace clean and organized, making it ideal for the use in a Class II safety cabinet.
An at-home olfactory test helps to identify people with an increased risk of having dopamine transporter imaging indicative of early Parkinson's disease, show data from the Parkinson Associated Risk Syndrome study.
Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518205152 | NPI | - | NPPES |
| 013191700 | Medicaid | FL | |
| 678415196 | Other | FL | MEDICAID WAIVER |
| 005978200 | Other | FL | MEDICAID WAIVER |
| 013190700 | Medicaid | FL |
| Provider Name | Phyllis A Lavigna |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1740547686 PECOS PAC ID: 3375770977 Enrollment ID: I20131205000650 |
News Archive
Of the more than 38,000 Americans diagnosed with renal cell carcinoma each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib - a standard frontline treatment for RCC.
VACUSIP is a portable benchtop vacuum aspiration system from INTEGRA that you can place wherever you need it. Besides increased mobility, the battery version of the VACUSIP allows you to keep the workspace clean and organized, making it ideal for the use in a Class II safety cabinet.
An at-home olfactory test helps to identify people with an increased risk of having dopamine transporter imaging indicative of early Parkinson's disease, show data from the Parkinson Associated Risk Syndrome study.
Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.
› Verified 8 days ago
| Provider Name | Elizabeth Ann Ferguson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1427476068 PECOS PAC ID: 8123307782 Enrollment ID: I20161122002076 |
News Archive
Of the more than 38,000 Americans diagnosed with renal cell carcinoma each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib - a standard frontline treatment for RCC.
VACUSIP is a portable benchtop vacuum aspiration system from INTEGRA that you can place wherever you need it. Besides increased mobility, the battery version of the VACUSIP allows you to keep the workspace clean and organized, making it ideal for the use in a Class II safety cabinet.
An at-home olfactory test helps to identify people with an increased risk of having dopamine transporter imaging indicative of early Parkinson's disease, show data from the Parkinson Associated Risk Syndrome study.
Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.
› Verified 8 days ago
| Provider Name | Timothy J Remmert |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1316335359 PECOS PAC ID: 3072888049 Enrollment ID: I20171002003089 |
News Archive
Of the more than 38,000 Americans diagnosed with renal cell carcinoma each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib - a standard frontline treatment for RCC.
VACUSIP is a portable benchtop vacuum aspiration system from INTEGRA that you can place wherever you need it. Besides increased mobility, the battery version of the VACUSIP allows you to keep the workspace clean and organized, making it ideal for the use in a Class II safety cabinet.
An at-home olfactory test helps to identify people with an increased risk of having dopamine transporter imaging indicative of early Parkinson's disease, show data from the Parkinson Associated Risk Syndrome study.
Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.
› Verified 8 days ago
| Provider Name | Barbara Hope |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1750594701 PECOS PAC ID: 5597994046 Enrollment ID: I20171120000452 |
News Archive
Of the more than 38,000 Americans diagnosed with renal cell carcinoma each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib - a standard frontline treatment for RCC.
VACUSIP is a portable benchtop vacuum aspiration system from INTEGRA that you can place wherever you need it. Besides increased mobility, the battery version of the VACUSIP allows you to keep the workspace clean and organized, making it ideal for the use in a Class II safety cabinet.
An at-home olfactory test helps to identify people with an increased risk of having dopamine transporter imaging indicative of early Parkinson's disease, show data from the Parkinson Associated Risk Syndrome study.
Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.
› Verified 8 days ago
News Archive
Of the more than 38,000 Americans diagnosed with renal cell carcinoma each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib - a standard frontline treatment for RCC.
VACUSIP is a portable benchtop vacuum aspiration system from INTEGRA that you can place wherever you need it. Besides increased mobility, the battery version of the VACUSIP allows you to keep the workspace clean and organized, making it ideal for the use in a Class II safety cabinet.
An at-home olfactory test helps to identify people with an increased risk of having dopamine transporter imaging indicative of early Parkinson's disease, show data from the Parkinson Associated Risk Syndrome study.
Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.
› Verified 8 days ago
Positive Transitions Of Central Florida Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 134 Old Sunbeam Dr, South Daytona, FL 32119 Phone: 386-846-4034 | |
Pamela G. Krones, Ph.d. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 138 Bryan Cave Rd, South Daytona, FL 32119 Phone: 512-740-8750 | |
Coastal Mental Health Center Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 801 Beville Rd Ste 202a, South Daytona, FL 32119 Phone: 407-347-6387 Fax: 888-217-4124 | |
Behavioral Foundation Centers Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2400 S Ridgewood Ave Ste 32, South Daytona, FL 32119 Phone: 904-878-8683 | |
Atlantic Psychiatric, L.l.c Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 719 Beville Rd, South Daytona, FL 32119 Phone: 386-304-3444 Fax: 386-304-3403 | |
Daytona Behavioral Health Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1635 S Ridgewood Ave Ste 201, South Daytona, FL 32119 Phone: 772-584-0452 |